U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C22H27FO5
Molecular Weight 390.4452
Optical Activity UNSPECIFIED
Defined Stereocenters 7 / 7
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of FLUPREDNIDENE

SMILES

C[C@]12C[C@H](O)[C@@]3(F)[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CC(=C)[C@]2(O)C(=O)CO

InChI

InChIKey=YVHXHNGGPURVOS-SBTDHBFYSA-N
InChI=1S/C22H27FO5/c1-12-8-16-15-5-4-13-9-14(25)6-7-19(13,2)21(15,23)17(26)10-20(16,3)22(12,28)18(27)11-24/h6-7,9,15-17,24,26,28H,1,4-5,8,10-11H2,2-3H3/t15-,16-,17-,19-,20-,21-,22-/m0/s1

HIDE SMILES / InChI

Molecular Formula C22H27FO5
Molecular Weight 390.4452
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 7 / 7
E/Z Centers 0
Optical Activity UNSPECIFIED

Fluprednidene (used in a form of fluprednidene 21-acetate) is a glucocorticoid developed for the treatment of inflammatory skin diseases. The drug is marketed under the name Decoderm in Europe.

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
DECODERM

Approved Use

For the treatment of inflammatory skin diseases, for example, atopic eczema (atopic dermatitis, endogenous eczema), contact dermatitis.
Doses

Doses

DosePopulationAdverse events​
0.1 % single, topical
Recommended
Dose: 0.1 %
Route: topical
Route: single
Dose: 0.1 %
Sources:
unhealthy, ADULT
Health Status: unhealthy
Age Group: ADULT
Sex: M+F
Food Status: UNKNOWN
Sources:
Disc. AE: Hypersensitivity...
AEs leading to
discontinuation/dose reduction:
Hypersensitivity
Sources:
AEs

AEs

AESignificanceDosePopulation
Hypersensitivity Disc. AE
0.1 % single, topical
Recommended
Dose: 0.1 %
Route: topical
Route: single
Dose: 0.1 %
Sources:
unhealthy, ADULT
Health Status: unhealthy
Age Group: ADULT
Sex: M+F
Food Status: UNKNOWN
Sources:
PubMed

PubMed

TitleDatePubMed
Double-blind comparison of miconazole/corticosteroid combination versus miconazole in inflammatory dermatomycoses.
1995-02
Dermal absorption of fluprednidene-21-acetate and miconazole from a new topical preparation in pigs.
1994-11
[Optimized interval treatment of eczema with fluprednidene. A multicenter double-blind study].
1989-09-15
Steroid-induced dermal atrophy. Investigations on discontinuous application.
1989
Patents

Sample Use Guides

Apply the cream to the affected skin areas once a day.
Route of Administration: Topical
In Vitro Use Guide
Unknown
Substance Class Chemical
Created
by admin
on Mon Mar 31 18:32:58 GMT 2025
Edited
by admin
on Mon Mar 31 18:32:58 GMT 2025
Record UNII
FA517NS3N7
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
FLUPREDNIDENE
INN   WHO-DD  
INN  
Official Name English
Fluprednidene [WHO-DD]
Preferred Name English
fluprednidene [INN]
Common Name English
Classification Tree Code System Code
WHO-ATC D07CB02
Created by admin on Mon Mar 31 18:32:58 GMT 2025 , Edited by admin on Mon Mar 31 18:32:58 GMT 2025
WHO-ATC D07XB03
Created by admin on Mon Mar 31 18:32:58 GMT 2025 , Edited by admin on Mon Mar 31 18:32:58 GMT 2025
WHO-VATC QD07XB03
Created by admin on Mon Mar 31 18:32:58 GMT 2025 , Edited by admin on Mon Mar 31 18:32:58 GMT 2025
WHO-VATC QD07CB02
Created by admin on Mon Mar 31 18:32:58 GMT 2025 , Edited by admin on Mon Mar 31 18:32:58 GMT 2025
NCI_THESAURUS C521
Created by admin on Mon Mar 31 18:32:58 GMT 2025 , Edited by admin on Mon Mar 31 18:32:58 GMT 2025
WHO-ATC D07AB07
Created by admin on Mon Mar 31 18:32:58 GMT 2025 , Edited by admin on Mon Mar 31 18:32:58 GMT 2025
WHO-VATC QD07AB07
Created by admin on Mon Mar 31 18:32:58 GMT 2025 , Edited by admin on Mon Mar 31 18:32:58 GMT 2025
Code System Code Type Description
RXCUI
236650
Created by admin on Mon Mar 31 18:32:58 GMT 2025 , Edited by admin on Mon Mar 31 18:32:58 GMT 2025
PRIMARY RxNorm
ChEMBL
CHEMBL2106763
Created by admin on Mon Mar 31 18:32:58 GMT 2025 , Edited by admin on Mon Mar 31 18:32:58 GMT 2025
PRIMARY
ECHA (EC/EINECS)
218-591-0
Created by admin on Mon Mar 31 18:32:58 GMT 2025 , Edited by admin on Mon Mar 31 18:32:58 GMT 2025
PRIMARY
CAS
2193-87-5
Created by admin on Mon Mar 31 18:32:58 GMT 2025 , Edited by admin on Mon Mar 31 18:32:58 GMT 2025
PRIMARY
FDA UNII
FA517NS3N7
Created by admin on Mon Mar 31 18:32:58 GMT 2025 , Edited by admin on Mon Mar 31 18:32:58 GMT 2025
PRIMARY
DRUG BANK
DB08970
Created by admin on Mon Mar 31 18:32:58 GMT 2025 , Edited by admin on Mon Mar 31 18:32:58 GMT 2025
PRIMARY
WIKIPEDIA
Fluprednidene
Created by admin on Mon Mar 31 18:32:58 GMT 2025 , Edited by admin on Mon Mar 31 18:32:58 GMT 2025
PRIMARY
DRUG CENTRAL
4553
Created by admin on Mon Mar 31 18:32:58 GMT 2025 , Edited by admin on Mon Mar 31 18:32:58 GMT 2025
PRIMARY
NCI_THESAURUS
C77421
Created by admin on Mon Mar 31 18:32:58 GMT 2025 , Edited by admin on Mon Mar 31 18:32:58 GMT 2025
PRIMARY
EPA CompTox
DTXSID30176343
Created by admin on Mon Mar 31 18:32:58 GMT 2025 , Edited by admin on Mon Mar 31 18:32:58 GMT 2025
PRIMARY
EVMPD
SUB07735MIG
Created by admin on Mon Mar 31 18:32:58 GMT 2025 , Edited by admin on Mon Mar 31 18:32:58 GMT 2025
PRIMARY
INN
2450
Created by admin on Mon Mar 31 18:32:58 GMT 2025 , Edited by admin on Mon Mar 31 18:32:58 GMT 2025
PRIMARY
PUBCHEM
11794741
Created by admin on Mon Mar 31 18:32:58 GMT 2025 , Edited by admin on Mon Mar 31 18:32:58 GMT 2025
PRIMARY
SMS_ID
100000080722
Created by admin on Mon Mar 31 18:32:58 GMT 2025 , Edited by admin on Mon Mar 31 18:32:58 GMT 2025
PRIMARY
Related Record Type Details
ACTIVE MOIETY